Regdanvimab
Product Specifications
CAS Number
2444308-95-4
Target
RAAS, SARS-CoV, Angiotensin-converting Enzyme (ACE)
Related Pathways
Endocrinology/Hormones, Metabolism, Microbiology/Virology
Purity
1
Bioactivity
Regdanvimab (CT-P59) is a humanized antibody targeting the spike protein of SARS-CoV-2, with antiviral activity. It prevents viral entry by blocking interactions with ACE2, used in studies of COVID-19 infection.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6328419-01 0.2 mL
OR2J3, CT (OR2J3, Olfactory receptor 2J3, Hs6M1-3, Olfactory receptor OR6-16) (Azide free) (HRP)
Sign In for Pricing
View Details MBS6328419-02 5x 0.2 mL
OR2J3, CT (OR2J3, Olfactory receptor 2J3, Hs6M1-3, Olfactory receptor OR6-16) (Azide free) (HRP)
Sign In for Pricing
View Details 
MBS6289213-01 0.2 mL
CSF2RA, CT (CSF2RA, CSF2R, CSF2RY, Granulocyte-macrophage colony-stimulating factor receptor subunit alpha, CDw116, CD116) (Azide free) (HRP)
Sign In for Pricing
View Details MBS6289213-02 5x 0.2 mL
CSF2RA, CT (CSF2RA, CSF2R, CSF2RY, Granulocyte-macrophage colony-stimulating factor receptor subunit alpha, CDw116, CD116) (Azide free) (HRP)
Sign In for Pricing
View Details